Evaluation of Novel <i>N</i>-(Dibenzylcarbamothioyl)benzamide Derivatives as Antibacterial Agents by Using DFT and Drug-Likeness Assessment

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Compounds</td><td class="align_center">HOMO (eV)</td><td class="align_center">LUMO (eV)</td><td class="align_center">HOMO-LUMO (eV)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left"><b>2a</b></td><td class="align_center">5.8295</td><td class="align_center">1.8492</td><td class="align_center">3.980</td></tr><tr><td class="align_left"><b>2b</b></td><td class="align_center">5.9541</td><td class="align_center">1.8229</td><td class="align_center">4.131</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>List of HOMO-LUMO energy of compounds <b>2a</b> and <b>2b</b>.</div>

Journal of Chemistry

tab3

Table 3

Table 3: Evaluation of Novel <i>N</i>-(Dibenzylcarbamothioyl)benzamide Derivatives as Antibacterial Agents by Using DFT and Drug-Likeness Assessment 

Journal of Chemistry

Evaluation of Novel N-(Dibenzylcarbamothioyl)benzamide Derivatives as Antibacterial Agents by Using DFT and Drug-Likeness Assessment

Table 3